BACKGROUND: A home haemodialysis programme (HHD) was established in Ireland in 2009 following studies suggesting better outcomes and a survival advantage when compared to conventional in-centre dialysis. AIM: The aim of this study was to assess the outcomes in patients commenced on the HHD programme. METHODS: Baseline characteristics, standard dialysis parameters, blood pressure control, antihypertensive usage, vascular access problems, hospitalisation rates and technical issues related to dialysis were analysed. RESULTS: Seventeen patients were followed over a 2-year period. Time spent travelling for dialysis-related treatments was reduced with time on dialysis per week increased. There was a trend towards lower blood pressure with nine patients, either discontinuing or having a reduction in antihypertensive medications. There were eight episodes of hospitalisation with the majority of complications related to vascular access. CONCLUSION: Home haemodialysis is a community-based therapy, offering an alternative to conventional in-centre haemodialysis in a select patient population.
BACKGROUND: A home haemodialysis programme (HHD) was established in Ireland in 2009 following studies suggesting better outcomes and a survival advantage when compared to conventional in-centre dialysis. AIM: The aim of this study was to assess the outcomes in patients commenced on the HHD programme. METHODS: Baseline characteristics, standard dialysis parameters, blood pressure control, antihypertensive usage, vascular access problems, hospitalisation rates and technical issues related to dialysis were analysed. RESULTS: Seventeen patients were followed over a 2-year period. Time spent travelling for dialysis-related treatments was reduced with time on dialysis per week increased. There was a trend towards lower blood pressure with nine patients, either discontinuing or having a reduction in antihypertensive medications. There were eight episodes of hospitalisation with the majority of complications related to vascular access. CONCLUSION: Home haemodialysis is a community-based therapy, offering an alternative to conventional in-centre haemodialysis in a select patient population.
Authors: Carolyn L Van Eps; Mark Jones; Tsun Ng; David W Johnson; Scott B Campbell; Nicole M Isbel; David W Mudge; Elaine Beller; Carmel M Hawley Journal: Hemodial Int Date: 2010-10 Impact factor: 1.812
Authors: Glenn M Chertow; Nathan W Levin; Gerald J Beck; Thomas A Depner; Paul W Eggers; Jennifer J Gassman; Irina Gorodetskaya; Tom Greene; Sam James; Brett Larive; Robert M Lindsay; Ravindra L Mehta; Brent Miller; Daniel B Ornt; Sanjay Rajagopalan; Anjay Rastogi; Michael V Rocco; Brigitte Schiller; Olga Sergeyeva; Gerald Schulman; George O Ting; Mark L Unruh; Robert A Star; Alan S Kliger Journal: N Engl J Med Date: 2010-11-20 Impact factor: 91.245
Authors: R M Fagugli; G Reboldi; G Quintaliani; P Pasini; G Ciao; B Cicconi; F Pasticci; J M Kaufman; U Buoncristiani Journal: Am J Kidney Dis Date: 2001-08 Impact factor: 8.860
Authors: Michael J Diamant; Lori Harwood; Sujana Movva; Barbara Wilson; Larry Stitt; Robert M Lindsay; Louise M Moist Journal: Clin J Am Soc Nephrol Date: 2009-12-17 Impact factor: 8.237
Authors: L U Mailloux; N Kapikian; B Napolitano; R T Mossey; A G Bellucci; B M Wilkes; M A Vernace; I J Miller Journal: Adv Ren Replace Ther Date: 1996-04
Authors: George O Ting; Carl Kjellstrand; Terri Freitas; Brian J Carrie; Shahrzad Zarghamee Journal: Am J Kidney Dis Date: 2003-11 Impact factor: 8.860
Authors: R W Evans; D L Manninen; L P Garrison; L G Hart; C R Blagg; R A Gutman; A R Hull; E G Lowrie Journal: N Engl J Med Date: 1985-02-28 Impact factor: 91.245